Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

Table 1 MeTA Health and Pharmaceutical Sector Financing Indicators by Country

INDICATOR	Ghana	Jordan	Kyrgyzstan	Peru	Philippines	Uganda	Zambia
Population (thousands), 2015	27409.9	7594.5	5940	31376.7	100699	39032.4	16211.8
GNI per capita (PPP int $), 2013	3880	11660	3070	11360	7820	1370	3070
Total expenditure on health as a proportion of GDP (%), 2014	3.56	7.45	6.48	5.47	4.71	7.22	4.99
General government expenditures on health as a percent of general government expenditures (%), 2014	6.82	13.68	11.92	15.00	10.01	10.97	11.31
Private expenditures on health as a percent of total health expenditures (%), 2014	40.15	30.32	43.87	39.36	65.72	75.06	44.65
Out-of-pocket payments as a percent of total health expenditures (%), 2014	26.84	20.87	39.4	28.62	53.69	40.96	22.99
Pharmaceuticals as a percent of total health expenditures (%)	27.3	35.9	33.0	22.4	41.1	52.2	18.4

Sources: WHO Global Health Observatory, MeTA Pharmaceutical Situation Assessment surveys, WHO Pharmaceutical Country Profiles, WHO World Medicines Situation Report, GNI Gross National Income, PPP purchasing power parity, GDP Gross Domestic Product